TB-HIV Factsheet 2018. Data Hub. (2018)

immage

Concerted and integrated efforts are needed to prevent and address both TB and TB-HIV burden in the region.

2 out of 3 TB infections globally are in Asia and the Pacific and 60% of MDR-TB burden is in this region. Globally, Asia and the Pacific is the home for 13% of PLHIV but 20% of TB-HIV co-infections are in this region. Systematic collaboration between TB-HIV programmes will save lives and improve the quality of life of people living with and affected by HIV and TB.


Keywords: Asia Pacific, TB-HIV, treatment, co-infections

 

Download Factsheet

Compendium of WHO Guidelines and Associated Standards: Ensuring Optimum Delivery of the Cascade of Care for Patients with Tuberculosis, Second Edition. WHO. (2018)

immage

The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or symptoms of TB in seeking diagnosis, treatment and care; and includes key algorithms and cross-cutting elements that are essential to a patient-centered approach in the cascade of TB care.


Keywords: TB, HIV, diagnosis, children, support

 

 

Download Publication

Bending the Curve - Keeping our Promise of Ending TB in the South-East Asia Region on Time. WHO, Regional Office for South-East Asia. (2018)

immage

The WHO South-East Asia (SEA) Region has some of the highest TB-burden countries, and nearly half of all TB cases in the world are to be found in people from this Region. The Region has nearly half the global burden in terms of new cases (incidence), and close to 40% of the burden in terms of deaths due to TB. And this while only 26% of the global population lives in the Region.

 

Keywords: TB, drug-resistant, treatment, funding

 

Download Publication

Global Tuberculosis Report 2018. WHO. (2018)

immage

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This is done in the context of recommended global TB strategies and targets endorsed by WHO’s Member States and broader development goals set by the United Nations. 

 

Keywords: TB, prevention, diagnosis, treatment, drug-resistant

 

Download 

 

- Full Report 


- Executive Summary


- Main Text


- Annex 1: The WHO Global TB Database


- Annex 2: Country Profiles for 30 High TB Burden Countries


- Technical Appendix: Methods to Estimate Eligibility for Latent TB Infection Treatment

Tuberculosis and HIV. UNAIDS. (2018)

immage

HIV-associated TB presents a risk to achieving the Sustainable Development Goals. Effective, sustained action is required to meet the needs of the most vulnerable populations.


United Nations Member States have committed to work towards the target of reducing deaths related to tuberculosis (TB) among people living with HIV by 75% by 2020, as well as reaching 90% of all people with TB with preventive or therapeutic treatment and achieving 90% treatment success for all people diagnosed with TB.

 

Keywords: TB, PLHIV, treatment, diagnostic, deaths

 

Download Publication

Roadmap towards Ending TB in Children and Adolescents. WHO. (2018)

immage

The 2018 United Nations General Assembly High-Level Meeting (HLM) on Tuberculosis and the current revision of the Roadmap for childhood tuberculosis together present an important moment to consolidate and advance advocacy, commitment, resource mobilization and joint efforts by all stakeholders to provide health care and address the burden of TB among children

 

 

Keywords: TB, HIV, multidrug-resistant, treatment, advocacy

 

Download Publication

Handbook for the Use of Digital Technologies to Support Tuberculosis Medication Adherence. WHO. (2018)

immage

TB patients and health-care providers are surrounded by information and communication technologies. They will be using these tools increasingly to obtain better care. However, in doing so they are often faced with basic questions, such as: Which application is best suited to my circumstances? What is the evidence for effectiveness? How do I implement it? Who will pay?

 

This handbook aims to address some of these questions. It focuses specifically on three technologies that are being widely used to help TB patients complete their treatment over the many months that their regimens last. 


Keywords: TB, medication, treatment, healthcare


Download Publication

Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis. WHO. (2017)

immage

The report – “Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including Mycobacterium tuberculosis” – shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance. Most of the drugs currently in the clinical pipeline are modifications of existing classes of antibiotics and are only short-term solutions. The report found very few potential treatment options for those antibiotic-resistant infections identified by WHO as posing the greatest threat to health, including drug-resistant tuberculosis which kills around 250 000 people each year. In addition to multidrug-resistant tuberculosis, WHO has identified 12 classes of priority pathogens – some of them causing common infections such as pneumonia or urinary tract infections – that are increasingly resistant to existing antibiotics and urgently in need of new treatments.


Keywords: TB, treatment, drugs, antibiotics

 

Download Publication

Bending the Curve - Ending TB: Annual Report 2017. WHO, Regional Office for South-East Asia. (2017)

immage

This is the second SEAR TB Report as we take first steps into the post 2015 era of the SDGs. In 2015, there was an estimated 4.74 million incidence of TB in the SEA Region, including HIV+TB co-infection. The total number of new cases notified to National TB programmes in the Region were around 2.65 million in appear staggering despite a reasonably good performance. Three countries that are poised well to eliminating TB by 2030 are Maldives, Bhutan and Sri Lanka. Nepal too is doing well despite the twin challenges of its mountainous terrain and coping with a major natural disaster. Timor-Leste, though small in terms of absolute TB numbers, faces a major challenge in bringing down its incidence rate.


Keywords: HIV, TB, ART, drug resistant, treatment

 

Download Publication

Ministerial Meeting towards Ending TB in the South-East Asia Region, 15-16 March 2017, New Delhi, India. WHO, Regional Office for South-East Asia. (2017)

immage

The two-day ministerial meeting held in Delhi was essentially aimed at raising the pitch on TB and garnering political commitment to end TB by 2030. From the above perspective the meeting was a resounding success considering that nine of 11 SEA Region health ministers attended the meeting promising to end TB with renewed momentum. Two countries had high level government representation. One of the core agendas of the meeting was framing the 'Call for Action' declaration and endorsing it by Member States. The 'Call for Action' declaration was signed by all SEA Region countries in an exemplary show of unity to 'bend the curve' and end TB. 


Keywords: HIV, TB, drug-resistant, treatment, diagnosis

 

 

Download Publication

 

Pages

database
Highlighted publications
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Monitoring_2018.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
http://www.aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events